Movatterモバイル変換

Jump to content

Chemical Evaluation of Betula Species in Japan. III. Constituents of Betula maximowicziana.(Q104913239)

From Wikidata

scientific article published on 8 December 2011

Language	Label	Description	Also known as
default for all languages	No label defined
English	Chemical Evaluation of Betula Species in Japan. III. Constituents of Betula maximowicziana.	scientific article published on 8 December 2011

Statements

scholarly article

0 references

Chemical Evaluation of Betula Species in Japan. III. Constituents of Betula maximowicziana.(English)

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

Betula maximowicziana

1 reference

(3R,5S,8R,9R,10R,12R,13R,14R,17R)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-1,2,3,5,6,7,9,11,12,13,15,16-dodecahydrocyclopenta[a]phenanthrene-3,12,17-triol

1 reference

3,4,5-trimethoxyphenyl-1-O-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranoside

1 reference

[(3S,5S,8R,9R,10R,13R,14R,17S)-17-[(E,2S)-2,7-dihydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

1 reference

[(3R,5S,8R,9R,10R,12R,13R,14R,17R)-3,17-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-1,2,3,5,6,7,9,11,12,13,15,16-dodecahydrocyclopenta[a]phenanthren-12-yl] acetate

1 reference

(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

1 reference

3alpha-(alpha-L-Rhamnopyranosyloxymethyl)-4beta-(3,5-dimethoxy-4-hydroxyphenyl)-5,7-dimethoxy-6-hydroxytetralin-2beta-methanol

1 reference

1 reference

[(3R,5S,8R,9R,10R,12R,13R,14R,17S)-3-hydroxy-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate

1 reference

1 reference

(3R,5S,8R,9R,10R,13S,14R,17R)-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-1,2,3,5,6,7,9,11,12,13,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol

1 reference

6-methoxykaempferol

1 reference

5,7,4'-Trihydroxy-3,6-dimethoxyflavone

1 reference

4,17-Dihydroxy-3-methoxytricyclo[12.3.1.12,6]nonadeca-1(17),2,4,6(19),14(18),15-hexaen-9-one

1 reference

(+)-catechin 7-O-beta-D-xyloside

1 reference

Lupane-3beta,20,28-triol

1 reference

[(3S,5S,8R,9R,10R,13R,14R,17S)-17-[(E,2S)-2,7-dihydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate

1 reference

Oleanolic acid 3-acetate

1 reference

1 reference

PGQCELLZPXFKMZ-NMKFIHLRSA-N

1 reference

(1R,3aR,3bR,5aS,7R,9aR,9bR,11R,11aR)-1-hydroxy-1-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-7-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-dodecahydrocyclopenta[a]phenanthren-11-yl acetate

1 reference

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(9S,11S)-3,11,17-trihydroxy-9-tricyclo[12.3.1.12,6]nonadeca-1(17),2,4,6(19),14(18),15-hexaenyl]oxy]oxane-3,4,5-triol

1 reference

(4aS,6aR,6aS,6bR,8aS,10S,12aR,14bS)-10-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid

1 reference

(3R,5S,8R,9R,10R,13R,14R,17S)-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

1 reference

[(3R,5S,8R,9R,10R,12R,13R,14R,17R)-3,17-dihydroxy-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-1,2,3,5,6,7,9,11,12,13,15,16-dodecahydrocyclopenta[a]phenanthren-12-yl] acetate

1 reference

1 reference

Dammarenediol II 3-O-caffeate

1 reference

3-(3,4-Dihydroxyphenyl)acrylic acid 20,28-dihydroxylupan-3beta-yl ester

1 reference

lupan-3beta,20-diol

1 reference

1 reference

1 reference

1 reference

1 reference

based on heuristic

inferred from title

author name string

Hiroyuki FUCHINO

1

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

Tetsuya SATOH

2

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

Nobutoshi TANAKA

3

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

publication date

1996

1 reference

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb1958/44/9/44_9_1748/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.44.1748?email=unpaywall_01@example.com

Chemical & Pharmaceutical Bulletin

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

44

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

9

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

1748-1753

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.44.1748

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.44.1748?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Identifiers

10.1248/CPB.44.1748

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q104913239&oldid=2106802085"

[8]ページ先頭

©2009-2025 Movatter.jp